Pyridinoylpiperidines as 5-HT1F agonists
US8044207B2 · kind B2 · utility
5Cited by
11References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 22, 2008 |
| Grant date | Oct 25, 2011 |
| Priority date | — |
| Expiry date | Jul 26, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula I: The compounds of the present invention are useful for activating 5-HT1F receptors, inhibiting neuronal protein extravasation, and for the treatment or prevention of migraine in a mammal. The present invention also relates to a process for the synthesis of intermediates in the synthesis of compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.